Manufacturing

Oct 15, 2018
By BioPharm International Editors
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
Oct 11, 2018
By BioPharm International Editors
The new facility will include comprehensive mammalian process development and manufacturing capabilities.
Oct 10, 2018
By BioPharm International Editors
The companies signed a three-year clinical manufacturing agreement to manufacture GlaxoSmithKline’s specific peptide enhanced affinity receptor T-cell receptor therapy for United States, Canadian, and European clinical trials.
Oct 10, 2018
By BioPharm International Editors
The companies will develop and commercialize ARO-HBV, a Phase I/II subcutaneous, ribonucleic acid interference therapy candidate being investigated for the treatment of chronic hepatitis B viral infection.
Oct 09, 2018
By BioPharm International Editors
The UCL-Pall Biotech Centre of Excellence will address industry challenges and provide workforce training.
Oct 03, 2018
By BioPharm International Editors
The companies will work together to discover, develop, and commercialize immunotherapies for patients with solid-tumor cancers in a collaboration worth $695 million per program.
Oct 01, 2018
BioPharm International
Non-destructive surface area measurement can improve stability testing.
Oct 01, 2018
BioPharm International
This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.
Oct 01, 2018
BioPharm International
The maturation of single-use technologies presents commercial bioprocessing options for small-volume drug products.
Oct 01, 2018
By BioPharm International Editors
The companies partnered to build a 500-L single-use pilot-scale plant for biologics production.
native1_300x100
lorem ipsum